glp-1 vs semaglutide difference Medications for Weight Loss: Tirzepatide vs Retat – Revolution Health & Wellness Semaglutide vs tirzepatide vs retatrutide:
Description
Particularly, tirzepatide is a dual GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor co-agonist, both marketed by Eli Lilly as Mounjaro for Type 2 diabetes and Zepbound for weight loss [7]

Semaglutides (Ozempic and Wegovy) are a class of molecules known as GLP-1 (Glucagon-like peptide 1) receptor agonists that mimic a hormone, GLP-1, in the body to increase the secretion of insulin, lower glucagon, control sugar spikes, and suppress appetite, leading to weight loss

Release date: May 1, 2026 Expiration date: April 30, 2027 ABSTRACT To reverse fibrosis in late-stage metabolic dysfunctionassociated steatohepatitis (MASH), guidelines recommend that patients shed at least 10% of their body weight

GLP-1 is a hormone that belongs to the incretin group Trusted Source PubMed Central Go to source

This medication can increase insulin sensitivity, decrease weight, and treat dyslipidemia at an early clinical stage, while also dramatically lowering blood sugar levels
